Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Change in Taxes (2022 - 2023)

Cullinan Therapeutics (CGEM) has 2 years of Change in Taxes data on record, last reported at -$4.2 million in Q2 2023.

  • For Q2 2023, Change in Taxes fell 109.05% year-over-year to -$4.2 million; the TTM value through Dec 2023 reached -$4.3 million, down 200.0%, while the annual FY2023 figure was -$4.3 million, 200.0% down from the prior year.
  • Change in Taxes reached -$4.2 million in Q2 2023 per CGEM's latest filing, down from -$75000.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $46.5 million in Q2 2022 and bottomed at -$35.1 million in Q3 2022.